CD20 Protein, Human, Recombinant (His & Avi), Biotinylated
Rif. TM-TMPK-00184
| 1mg | 5.163,00 € | ||
| 100µg | 798,00 € | ||
| 500µg | 3.085,00 € |
Informazioni sul prodotto
- MS4A-1, CD20, B-lymphocyte surface antigen B1, Membrane-spanning 4-domains subfamily A member 11, Leukocyte surface antigen Leu-16, Bp35, MS4A1
B-lymphocyte antigen CD20 or CD20 is an activated-glycosylated phosphoprotein expressed on the surface of all B-cells beginning at the pro-B phase (CD45R , CD117) and progressively increasing in concentration until maturity.CD20 is the target of the monoclonal antibodies rituximab, ocrelizumab, obinutuzumab, ofatumumab, ibritumomab tiuxetan, tositumomab, and ublituximab, which are all active agents in the treatment of all B cell lymphomas, leukemias, and B cell-mediated autoimmune diseases. CD20 Protein, Human, Recombinant (His & Avi), Biotinylated is expressed in E. coli expression system with C-His-Avi tag. The predicted molecular weight is 16.8 kDa and the accession number is P11836-1.
Proprietà chimiche
Richiesta tecnica su: TM-TMPK-00184 CD20 Protein, Human, Recombinant (His & Avi), Biotinylated
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.
